Fecal microbiome therapy to clear hard-to-treat gut germs
Part of Infections clinical trials.
This trial looks at a treatment made from stool donors (called fecal microbiome therapy) to help remove carbapenem-resistant gut bacteria in the body. It’s mainly for adults who recently tested positive for these bacteria on a rectal swab, and it checks whether the therapy can help eradicate the germs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You need a recent rectal swab test showing carbapenem-resistant bacteria within the last 15 days.
- You must be able to complete study procedures and sign consent.
- You should not have ongoing long-term stomach or bowel problems (chronic GI disorders).
- You should not have had prior surgery on your colon or rectum.
- You should not be pregnant or breastfeeding, and you should not have major other health problems or psychiatric conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
This Phase 3 study tests whether a fecal microbiota transplant (FMT) can eliminate hard-to-treat bacteria in the gut, such as ESBL or carbapenem-resistant bacteria. If it works, it may reduce future infections and antibiotic-resistant illness.
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
This trial tests whether a stool (fecal) transplant from a screened donor can help remove antibiotic-resistant gut bacteria (MDRO) that keep coming back in your stool tests. It aims to reduce colonization that makes follow-up and treatment harder.
This trial tests three different ways to clear antibiotic-resistant bacteria from your gut using fecal microbiota transplant (FMT). It may help if you have a confirmed resistant infection and are looking for a treatment to reduce the risk of future infections.
This trial tests whether a fecal microbiota transplant (transferring healthy bacteria from a donor) can help clear multidrug-resistant bacteria from your body. It may be an option if you have such bacteria and are looking for a way to remove them.
Hear when a new Enterobacteriaceae Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.